Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q06643 (
non-Hodgkin's lymphoma
)
11,307
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cytophotometric DNA determinations on 26 cases of
non-Hodgkin's lymphoma
yielded the following findings: 1. Follicular centrocytic/centroblastic lymphomas (M. Brill-Symmers) and diffuse centrocytic lymphomas (lymphocytic lymphosarcoma) have a diploid DNA stem line. Diploid DNA values are observed in benign tumors, so that the assignment of these lymphomas to the group of "low grade malignancies" appears justified. 2. Lymphoblastic sarcomas show an aneuploid DNA stem line, as do 96% of all malignant tumors. 3. Lymphoid cells, plasma cells, and immunoblasts seen in immunocytomas are aneuploid. Thus these lymphomas must belong to the group of "high-grade malignant lymphomas" as regards their DNA distribution. 4.
Immunoblastic
sarcomas have aneuploid DNA stem lines (1 case tetraploid), in which both the lymphoid cells and the plasma cells from those immunoblastic sarcomas arising from immunocytomas show atypical DNTA distribution patterns. 5. In two cases of angioimmunoblastic lymphadenopathy, the lymphoid cells, plasma cells, and immunoblasts are aneuploid. They are thus regarded as "high grade malignancy" lymphomas. The results are discussed with respect to clinical course and prognosis. Measurements on a larger series of cases and correlation to clinical data are needed to support these results. Ultrafast DNA measurements made by flow-through cytophotometry can perhaps be helpful in the future for making the decision between a "low" or "high" grade malignant lymphoma.
...
PMID:DNA in non Hodgkin-lymphoma--a cytophotometric study. 33 46
The total
non-Hodgkin's lymphoma
-population treated between 1978 and 1986 by means of radiotherapy or combined chemo/radiotherapy was analysed as to primary extranodular manifestation. 39 cases, 16 women and 23 men, were observed (stage IE 12, stage IIE 22 and stage IIIE 5).
Immunoblastic
(10), lymphoblastic (9) and centroblastic (6) lymphomas are the most frequent with respect to histology. Gastroenteron (16) and otorhinolaryngological region (13) are in the lead with regard to localisation. 5-year-survival-rates are determined in dependence on clinical stage: IE 65.8%, IIE 39.2% (low, connected with the proportion of high-malignant histology) and IIIE 25.0%. The 5-year-survival-rate of primary gastrointestinal manifestation amounted to 51.5%. With respect to aetiopathogenesis of primary extranodular lymphomas gut-, mucosa- and bronchial-associated lymphoid tissue, aberrant lymph-nodes and the influence of viral- and immunologic factors seem to be important.
...
PMID:[Primary extranodular non-Hodgkin's lymphomas--observations on etiopathogenesis, histology and prognosis]. 338 18
Ultrastructural studies of five T cell immunoblastic sarcomas revealed morphologic features that uniquely distinguished this variant of
non-Hodgkin's lymphoma
.
Immunoblastic
sarcomas of T cell type were characterized by large lymphoid cells with striking electron-lucent cytoplasm with few organelles. Neoplastic cells of B cell immunoblastic sarcomas (5 cases) clearly differed, in that they contained numerous cytoplasmic polysomal aggregates and long, irregular strands of rough endoplasmic reticulum, occasionally with dilated cisternae. Light microscopic features were correlated with these ultrastructural distinctions. T immunoblasts correspond to large lymphoid cells with pale to clear cytoplasm, in contrast to B immunoblasts, which exhibit amphophilic cytoplasm and/or plasmacytoid differentiation. These morphologic characteristics may be helpful in identification and classification of immunoblastic sarcomas of T and B cell types.
...
PMID:Immunoblastic sarcoma of the T cell type: an ultrastructural study of five cases. 696 48